Your browser doesn't support javascript.
loading
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.
Papillon-Cavanagh, Simon; Lu, Chao; Gayden, Tenzin; Mikael, Leonie G; Bechet, Denise; Karamboulas, Christina; Ailles, Laurie; Karamchandani, Jason; Marchione, Dylan M; Garcia, Benjamin A; Weinreb, Ilan; Goldstein, David; Lewis, Peter W; Dancu, Octavia Maria; Dhaliwal, Sandeep; Stecho, William; Howlett, Christopher J; Mymryk, Joe S; Barrett, John W; Nichols, Anthony C; Allis, C David; Majewski, Jacek; Jabado, Nada.
Afiliação
  • Papillon-Cavanagh S; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Lu C; Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York, USA.
  • Gayden T; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Mikael LG; Department of Pediatrics, McGill University and McGill University Heath Centre Research Institute, Montreal, Quebec, Canada.
  • Bechet D; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Karamboulas C; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Ailles L; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Karamchandani J; Department of Pathology, Montreal Neurological Hospital, McGill University, Montreal, Quebec, Canada.
  • Marchione DM; Epigenetics Program, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Garcia BA; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Weinreb I; Epigenetics Program, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Goldstein D; Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  • Lewis PW; Department of Otolaryngology and Department of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Dancu OM; Wisconsin Institute for Discovery and Department of Biomolecular Chemistry, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
  • Dhaliwal S; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Stecho W; Department of Otolaryngology-Head and Neck Surgery, University of Western Ontario, London, Ontario, Canada.
  • Howlett CJ; Department of Oncology, University of Western Ontario, London, Ontario, Canada.
  • Mymryk JS; Department of Pathology and Laboratory Medicine, University of Western Ontario, London, Ontario, Canada.
  • Barrett JW; Department of Pathology and Laboratory Medicine, University of Western Ontario, London, Ontario, Canada.
  • Nichols AC; Department of Microbiology and Immunology, Oncology and Otolaryngology-Head and Neck Surgery, University of Western Ontario, London, Ontario, Canada.
  • Allis CD; London Regional Cancer Program and Lawson Health Research Institute, London, Ontario, Canada.
  • Majewski J; Department of Otolaryngology-Head and Neck Surgery, University of Western Ontario, London, Ontario, Canada.
  • Jabado N; Department of Oncology, University of Western Ontario, London, Ontario, Canada.
Nat Genet ; 49(2): 180-185, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28067913
ABSTRACT
Human papillomavirus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs) are deadly and common cancers. Recent genomic studies implicate multiple genetic pathways, including cell signaling, cell cycle and immune evasion, in their development. Here we analyze public data sets and uncover a previously unappreciated role of epigenome deregulation in the genesis of 13% of HPV-negative HNSCCs. Specifically, we identify novel recurrent mutations encoding p.Lys36Met (K36M) alterations in multiple H3 histone genes. histones. We further validate the presence of these alterations in multiple independent HNSCC data sets and show that, along with previously described NSD1 mutations, they correspond to a specific DNA methylation cluster. The K36M substitution and NSD1 defects converge on altering methylation of histone H3 at K36 (H3K36), subsequently blocking cellular differentiation and promoting oncogenesis. Our data further indicate limited redundancy for NSD family members in HPV-negative HNSCCs and suggest a potential role for impaired H3K36 methylation in their development. Further investigation of drugs targeting chromatin regulators is warranted in HPV-negative HNSCCs driven by aberrant H3K36 methylation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histonas / Carcinoma de Células Escamosas / Metilação de DNA / Neoplasias de Cabeça e Pescoço Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histonas / Carcinoma de Células Escamosas / Metilação de DNA / Neoplasias de Cabeça e Pescoço Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article